| Product NDC: | 52959-620 |
| Proprietary Name: | Cephalexin |
| Non Proprietary Name: | Cephalexin |
| Active Ingredient(s): | 250 mg/5mL & nbsp; Cephalexin |
| Administration Route(s): | ORAL |
| Dosage Form(s): | FOR SUSPENSION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 52959-620 |
| Labeler Name: | H.J. Harkins Company, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA065234 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20050801 |
| Package NDC: | 52959-620-00 |
| Package Description: | 100 mL in 1 BOTTLE (52959-620-00) |
| NDC Code | 52959-620-00 |
| Proprietary Name | Cephalexin |
| Package Description | 100 mL in 1 BOTTLE (52959-620-00) |
| Product NDC | 52959-620 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Cephalexin |
| Dosage Form Name | FOR SUSPENSION |
| Route Name | ORAL |
| Start Marketing Date | 20050801 |
| Marketing Category Name | ANDA |
| Labeler Name | H.J. Harkins Company, Inc. |
| Substance Name | CEPHALEXIN |
| Strength Number | 250 |
| Strength Unit | mg/5mL |
| Pharmaceutical Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] |